Bhagwant Rege

Title: Innovations by Bhagwant Rege

Introduction

Bhagwant Rege is a notable inventor based in Collegeville, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative formulations. With a total of 3 patents to his name, Rege's work focuses on enhancing the efficacy of various pharmaceutical compositions.

Latest Patents

One of Bhagwant Rege's latest patents is titled "Formulations for Cathepsin K Inhibitors." This invention relates to pharmaceutical compositions that contain cathepsin K inhibitors, along with processes for creating these compositions. Another significant patent is "Self-Emulsifying Formulations of CETP Inhibitors." This patent describes a liquid formulation for oral administration of the CETP inhibitor, which boasts improved bioavailability compared to conventional solid formulations. The formulation includes the CETP inhibitor or a pharmaceutically acceptable salt, an oil, and one or more nonionic surfactants with a hydrophilic lipophilic balance (HLB) greater than 10.

Career Highlights

Bhagwant Rege is currently associated with Merck Sharp & Dohme Corporation, where he continues to innovate in the pharmaceutical sector. His work has contributed to advancements in drug formulations that aim to improve patient outcomes.

Collaborations

Rege has collaborated with notable colleagues such as Craig A McKelvey and Justin Moser, enhancing the collaborative spirit of innovation within his field.

Conclusion

Bhagwant Rege's contributions to pharmaceutical formulations demonstrate his commitment to advancing medical science. His innovative patents reflect a dedication to improving drug efficacy and patient care.